Yejun Tan
Overview
Explore the profile of Yejun Tan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang S, Jiang Y, Huang T, Ho K, Tan Y, Zhu L, et al.
Public Health
. 2025 Jan;
239:162-168.
PMID: 39836997
Objectives: This study aimed to explore the characteristics, overall anxiety and depression status, and influencing factors of only-child and non-only-child students by examining a medical student population in the post-COVID-19...
2.
Zhong A, Tan Y, Liu Y, Chai X, Peng W
J Am Heart Assoc
. 2024 Jul;
13(15):e032814.
PMID: 39082403
Background: The association between poor cardiovascular health and cognitive decline as well as dementia progression has been inconsistent across studies. This study used Mendelian randomization (MR) to investigate the causal...
3.
Zheng Q, Wang Z, Tan Y, Zhu K, Lu M
Rheumatol Ther
. 2024 Jul;
11(5):1255-1269.
PMID: 39073510
Introduction: Juvenile dermatomyositis (JDM) is characterized by persistent non-purulent inflammation in the muscle and skin. The underlying mechanisms still remain uncertain. This study aims to elucidate the mechanism of interleukin-6...
4.
Huang Y, Ren H, Tan Y
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1397644.
PMID: 38596228
No abstract available.
5.
Cheng X, Tan Y, Li H, Zhang Z, Hui S, Zhang Z, et al.
Mol Neurobiol
. 2024 Mar;
61(10):8253-8278.
PMID: 38483656
Diabetic encephalopathy (DE) is a complication of diabetes, especially type 2 diabetes (T2D), characterized by damage in the central nervous system and cognitive impairment, which has gained global attention. Despite...
6.
Zheng P, Tan Y, Liu Q, Wu C, Kang J, Liang S, et al.
Heliyon
. 2024 Mar;
10(5):e26993.
PMID: 38468942
Background: Hematopoietic cell signal transducer (HCST) and tyrosine kinase-binding protein (TYROBP) are triggering receptors expressed on myeloid cells 2 (TREM2), which are pivotal in the immune response to disease. Despite...
7.
Liu Y, Tan Y, Zhang Z, Yi M, Zhu L, Peng W
Transl Neurodegener
. 2024 Jan;
13(1):7.
PMID: 38254235
Ageing is a crucial risk factor for Alzheimer's disease (AD) and is characterised by systemic changes in both intracellular and extracellular microenvironments that affect the entire body instead of a...
8.
Yang D, Tan Y, Xie X, Xiao W, Kang J
Int Immunopharmacol
. 2023 Sep;
115:109720.
PMID: 37724956
Aseptic loosening caused by inflammatory osteolysis is one of the most frequent and serious long-term complications after total joint arthroplasty (TJA). Development of a new therapeutic drug is required due...
9.
Liu Y, Li H, Wang X, Huang J, Zhao D, Tan Y, et al.
J Transl Med
. 2023 Apr;
21(1):277.
PMID: 37095548
Background: Icariin (ICA), an active ingredient extracted from Epimedium species, has shown promising results in the treatment of Alzheimer's disease (AD), although its potential therapeutic mechanism remains largely unknown. This...
10.
Tan Y, Kang J, Li H, Zhong A, Liu Y, Zhang Z, et al.
Front Immunol
. 2023 Apr;
14:1149810.
PMID: 37033970
Background: Patients with diabetes mellitus (DM) have a higher incidence of malignant tumors than people without diabetes, but the underlying molecular mechanisms are still unclear. Methods: To investigate the link...